Haematological Cancer

At BioInvent, we are focusing on developing and producing antibody-based drugs to treat haematological cancer as well as therapies that activate normal blood cells to treat several types of cancer.

There are many types of cells with different functions in the blood and all of them can be turned into cancer cells. Lymphocytes (B-lymphocytes and T-lymphocytes) and myeloid cells may cause various types of haematological cancer, such as lymphoma, leukaemia and myeloma.